Cite
HARVARD Citation
Augustsson, J. et al. (2010). Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry). Annals of the rheumatic diseases. 69 (01), pp. 126-131. [Online].